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The DNA damage and the DNA replication 
checkpoints converge at the MBF transcription 
factor
Tsvetomira Ivanovaa,*, Isabel Alves-Rodriguesa,*, Blanca Gómez-Escodaa, Chaitali Duttab, 
James A. DeCaprioc, Nick Rhindb, Elena Hidalgoa, and José Aytéa
aOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, Barcelona 08003, Spain; bDepartment of 
Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605; 
cDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115
ABSTRACT In fission yeast cells, Cds1 is the effector kinase of the DNA replication check-
point. We previously showed that when the DNA replication checkpoint is activated, the re-
pressor Yox1 is phosphorylated and inactivated by Cds1, resulting in activation of MluI-bind-
ing factor (MBF)–dependent transcription. This is essential to reinitiate DNA synthesis and for 
correct G1-to-S transition. Here we show that Cdc10, which is an essential part of the MBF 
core, is the target of the DNA damage checkpoint. When fission yeast cells are treated with 
DNA-damaging agents, Chk1 is activated and phosphorylates Cdc10 at its carboxy-terminal 
domain. This modification is responsible for the repression of MBF-dependent transcription 
through induced release of MBF from chromatin. This inactivation of MBF is important for 
survival of cells challenged with DNA-damaging agents. Thus Yox1 and Cdc10 couple normal 
cell cycle regulation in unperturbed conditions and the DNA replication and DNA damage 
checkpoints into a single transcriptional complex.
INTRODUCTION
Genomic integrity is constantly threatened by many processes that 
take place in any living cell. Processes like transcription and DNA 
replication and exposure to external or internal damaging agents 
represent for the cell increased risk of rearrangements in DNA or 
single-nucleotide substitutions, defects that are the hallmarks of 
cancer cells (Elledge, 1996; Ciccia and Elledge, 2010). To maintain 
genomic integrity, all eukaryotes have developed a highly conserved 
mechanism to detect, signal, and repair damage in DNA, known as 
the DNA damage response (Hartwell and Weinert, 1989; Elledge, 
1996; Rhind and Russell, 1998). When DNA replication is challenged, 
cells activate a DNA replication checkpoint blocking cell cycle pro-
gression until they are able to overcome the replication defects 
(Murakami and Okayama, 1995; Boddy and Russell, 1999). Similarly, 
in response to damage to DNA, cell cycle must be arrested through 
the DNA damage checkpoint (Rhind and Russell, 2000). In the fission 
yeast Schizosaccharomyces pombe the effector kinases Cds1 and 
Chk1 are activated by the DNA replication and the DNA damage 
checkpoint, respectively. The main aim of these kinases is to block 
cell cycle progression before cells enter into mitosis by phosphory-
lating and inhibiting the phosphatase Cdc25, which fully prevents 
activation of Cdc2 (Walworth et al., 1993; Furnari et al., 1997).
In fission yeast, activation of Cds1 in response to a DNA replica-
tion defect also invokes a transcriptional response that ultimately 
increases the concentration of the deoxynucleotides required to 
complete DNA synthesis. This response is achieved by activating 
the transcription factor MluI-binding factor (MBF; Dutta et al., 2008), 
which in a normal—unperturbed—cell cycle is responsible for the 
transcription of a set of genes that are required for the S phase of 
the cell cycle (Lowndes et al., 1992). MBF, which is the functional 
homologue of mammalian RB/E2F, is a high–molecular weight com-
plex whose core elements are the product of the Start gene cdc10 
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released from chromatin after treatment with MMS (Figure 2C), 
pointing to the possibility that the core elements of MBF (Res1, 
Res2, and Cdc10) are released as a complex from chromatin (and 
not as individual components) after the DNA damage checkpoint is 
induced.
The effect of the DNA damage checkpoint on MBF 
is dose dependent
To further characterize the response to MMS, we treated cells with 
increasing concentrations of the drug (from 0.002 to 0.1%) for 60 
min. At the lower doses, we could not observe any noticeable effect 
on Cdc10, since it remained bound to the canonical promoters that 
we tested. In fact, Cdc10 was not released from chromatin unless 
cells were treated with higher MMS concentrations (≥0.05%; Figure 
3A). On the contrary, when we measured the effect of MMS on the 
and Res1 and Res2, which form a heterodimeric DNA-binding do-
main (Simanis and Nurse, 1989; Lowndes et al., 1992; Tanaka et al., 
1992; Miyamoto et al., 1994; Obara-Ishihara and Okayama, 1994; 
Ayte et al., 1995). Under replicative stress, the activation of MBF-
dependent transcription is a consequence of phosphorylation of 
several components of the MBF complex, including Cdc10 (Dutta 
et al., 2008), the corepressor Nrm1 (de Bruin et al., 2008), the re-
pressor Yox1 (Caetano et al., 2011; Gomez-Escoda et al., 2011; 
Purtill et al., 2011), and the coactivator Rep2 (Nakashima et al., 
1995; Chu et al., 2007, 2009). Specifically, phosphorylation of Yox1 
by Cds1 disrupts the binding of Yox1 to the MBF complex, activat-
ing MBF-dependent transcription. Mutants in which Yox1 cannot be 
phosphorylated lack the proper transcriptional response under rep-
licative stress (Gomez-Escoda et al., 2011). In this work, we demon-
strate that there is also a direct link between the DNA damage 
checkpoint and the MBF complex, which, contrary to what happens 
after the activation of the DNA replication checkpoint, is responsible 
for inactivating the transcription of S-phase genes. This is achieved 
by direct phosphorylation of Cdc10 at Ser-720 and Ser-732 by the 
effector kinase Chk1.
RESULTS
Cdc10 is targeted by the DNA damage checkpoint
While investigating the effect of the DNA replication checkpoint on 
the regulation of the transcription factor MBF, we noticed that when 
cells were treated with hydroxyurea (HU) on a Yox1 mutant back-
ground (Yox1.SATA) that cannot be phosphorylated by the DNA 
replication checkpoint effector kinase Cds1, MBF-dependent induc-
tion of transcription was abrogated (Figure 1A; Gomez-Escoda 
et al., 2011). Under these conditions, the core MBF element, Cdc10, 
was released from chromatin (Figure 1B), in parallel to the release of 
the repressor Yox1 (Figure 1C). We were able to observe this release 
independent of the presence of Cds1, since in cells lacking Cds1, 
Cdc10 was also released when they were treated with HU and to a 
similar extent as in the Yox1.SATA cells. Unexpectedly, this release 
of Cdc10 was abrogated in the absence of Chk1 (both Δchk1 and 
Δchk1Δcds1 strains) or when Chk1 could not be activated in cells 
that lack the sensor kinase (Δrad3 strain). Of interest, we were able 
to observe that Chk1 was phosphorylated (which is a hallmark of its 
activation) when either Yox1.SATA or Δcds1 cells were treated with 
HU, pointing to the fact that in these specific genetic backgrounds 
both the DNA replication and DNA damage checkpoints were acti-
vated by HU (Figure 1D).
It was previously shown that, besides Yox1, other components of 
the MBF complex (Nrm1 and Cdc10) could be phosphorylated by 
Cds1 when cells were under replicative stress (de Bruin et al., 2008; 
Dutta et al., 2008). However, our previous results (Figure 1) pointed 
to the possibility that some MBF components could also be tar-
geted by Chk1 specifically when the DNA damage checkpoint was 
activated. To further investigate the signaling from this checkpoint 
to the MBF factor, we treated fission yeast cells with different DNA-
damaging agents, such as MMS and γ-irradiation (Figure 2A). In-
deed, both damaging agents were able to induce the release of 
Cdc10 from two of the better-characterized MBF-dependent pro-
moters, cdc18 and cdc22. To determine whether Cdc10 was re-
leased alone or with other components of the MBF complex, we 
decided to test for coimmunoprecipitation between Cdc10 and 
Res2, which contains the DNA-binding activity of the MBF complex 
in its amino-terminal region (Miyamoto et al., 1994; Obara-Ishihara 
and Okayama, 1994). As shown in Figure 2B, the interaction be-
tween Cdc10 and Res2 was well preserved, if not improved, after 
treating fission yeast cells with MMS. In fact, both Res1 and Res2 are 
FIGURE 1: Cdc10 is targeted by the DNA damage response. (A) Total 
RNA was prepared from untreated (–) or HU-treated (+) cultures of 
wild-type (WT) and Yox1.SATA (SATA) cells and analyzed by 
hybridization to the probes indicated on the left. rRNA is shown as 
loading control. (B) Loading of Cdc10 on cdc22 and cdc18 promoters 
was measured by chromatin immunoprecipitation analysis of 
chromatin extracts isolated from untreated or HU-treated (10 mM HU, 
4 h at 30°C) cultures of WT, SATA, Δcds1, Δchk1, Δcds1Δchk1, or 
Δrad3 cells. Endogenous Cdc10 is HA tagged, and the levels of 
binding are quantified on anti-HA immunoprecipitated DNA. (C) The 
same chromatin extracts analyzed for Yox1 binding with anti-Yox1 
polyclonal antibodies. (D) Phosphorylation level of endogenous 
Chk1-HA in native extracts prepared from untreated (−) or HU-treated 
(+) cultures of WT, SATA, or Δcds1 strains. Proteins were resolved in 
8% SDS–PAGE and anti-HA Western blotted to detect Chk1.
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viability of the cells during the time of treatment. As shown in Figure 
3D and Supplemental Figure S1, the MMS concentrations used (and 
even higher concentrations) barely affect cell viability during the 
time of treatment.
Next we wanted to further characterize the signaling from the 
DNA damage checkpoint to the MBF complex. To confirm that re-
lease of Cdc10 was exclusively due to activation of the DNA dam-
age checkpoint (and that the DNA replication checkpoint was not 
involved in this release), we analyzed the binding of Cdc10 and Yox1 
to cdc18 and cdc22 promoters in cells with impaired signaling in 
each or both of these checkpoint-signaling pathways after treat-
ment with MMS. As shown in Figure 4A, the release of Cdc10 in cells 
lacking Cds1 was similar to that in wild-type cells. However, in cells 
repressor system (Nrm1 and Yox1), we clearly observed that both 
proteins were released from chromatin (and consequently from the 
MBF complex) already at the lower MMS concentrations (Figure 3A). 
This effect on Nrm1/Yox1 paralleled a noticeable induction of the 
transcription of the MBF genes at low MMS concentrations (Figure 
3B). We detected further release of both Yox1 and Nrm1 when we 
treated cells with higher MMS concentrations, which paralleled the 
described release of Cdc10. This second wave of Nrm1 and Yox1 
release at higher concentrations correlates with repression of MBF-
dependent transcription at higher MMS doses (Figure 3B). To sepa-
rate both events (Cdc10 release at higher concentrations and Nrm1/
Yox1 release at lower concentrations) and determine whether the 
DNA damage checkpoint was indeed able to induce release of the 
MBF complex from chromatin (and its consequent down-regulation 
of the MBF-dependent transcription), we decided to repeat the 
MMS treatment in a strain lacking the repressor system (Δnrm1Δyox1 
background strain). These cells, which have induced transcription of 
the MBF-dependent genes as their basal steady state, were ex-
posed to increasing MMS concentration for 1 h. As shown in Figure 
3C, clear repression of the two MBF-dependent genes (cdc18 and 
cdc22) was observed. To determine whether release of the MBF 
complex from chromatin was due to cell death, we measured the 
FIGURE 2: The DNA damage response releases intact MBF from its 
target promoters. (A) Loading of Cdc10 on cdc22 and cdc18 
promoters was measured by chromatin immunoprecipitation (ChIP) 
analysis with anti-Cdc10 polyclonal antibodies of chromatin extracts 
isolated from untreated or MMS-treated (0.1% for 1 h at 30ºC) 
cultures of WT strain (left) or from irradiated cells (100 Gy; right). 
(B) The interaction between Cdc10 and Res2 is preserved in MMS-
treated cells. Extracts (2.5 mg) from WT and Cdc10-HA strains (with 
or without MMS treatment for the time indicate on top) were 
immunoprecipitated with anti-HA antibody and analyzed for the 
presence of Res2 and Cdc10 with specific antibodies (monoclonal 
anti-Res2 and anti-HA, respectively). (C) Loading of Res1 (left) or Res2 
(right) on cdc22 and cdc18 promoters was measured by ChIP analysis 
of chromatin extracts isolated from untreated or MMS-treated (0.1% 
for 1 h at 30ºC) cultures of a Res1-HA or Res2-HA strain, respectively.
FIGURE 3: Chk1 effect on Cdc10 depends on MMS concentration. 
(A) Loading of Cdc10, Yox1, and Nrm1-HA on cdc22 and cdc18 
promoters was measured by ChIP analysis of chromatin extracts 
isolated from untreated or MMS-treated cultures with the indicated 
concentrations (1 h at 30ºC). Cdc10 and Nrm1 are HA tagged, and 
the levels of binding are quantified on anti-HA immunoprecipitated 
DNA, whereas Yox1 is determined with anti-Yox1polyclonal 
antibodies. (B) Total RNA was prepared from untreated (–) or 
MMS-treated cultures of wild-type cells and analyzed by hybridization 
to the probes indicated on the left. rRNA is shown as loading control. 
(C) Total RNA was prepared from untreated or MMS-treated 
(increasing doses) cultures of Δyox1Δnrm1 cells and analyzed by 
hybridization with the probes indicated on the left. rRNA is shown as 
loading control. (D) Cell viability is unaffected at the used range of 
MMS concentrations. Viability test of wild-type cells treated with 
different concentrations of MMS, using propidium iodide or phloxine 
to measure viable cells, was performed by fluorescence-activated cell 
sorting analysis.
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are in close proximity to the ankyrin domain, which mediates pro-
tein–protein interactions, the last two residues are in the C-terminal 
region of Cdc10, which is essential for loading the Yox1/Nrm1 re-
pressor system onto chromatin (Supplemental Figure S2). In fact, 
and as a first approach, we noticed that Cdc10 release after MMS 
treatment was not observed in a strain that lacks the last 61 amino 
acids of Cdc10, cdc10-C4 (Figure 5A). Thus we decided to focus on 
this carboxy-terminal domain of Cdc10 as a potential substrate of 
Chk1 phosphorylation. In fact, in our in vitro Chk1 kinase assays, a 
Cdc10 construct lacking the last 61 amino acids was not phosphory-
lated. Conversely, a construct containing only the carboxy-terminal 
61 amino acids (and thus containing the last two putative phospho-
rylation sites) was consistently phosphorylated (Figure 5, B and C). 
When Ser-720 or Ser-732 was mutated to alanine, the extent of 
phosphorylation was diminished. Furthermore, in the double mu-
tant, Cdc10 phosphorylation by Chk1 was completely abolished 
(Figure 5C). It is worth noting that these phosphorylation sites are 
partially different from the described as Cds1-phosphorylation sites 
in Cdc10, where the authors noticed that only when both Ser-720 
and Thr-723 were mutated to glutamic acid was MBF-dependent 
transcription induced (Dutta et al., 2008). In fact, in this mutant back-
ground, the Nrm1/Yox1 repressor system is unable to bind the MBF 
complex (unpublished data). Next, to determine whether in vivo 
Chk1 was able to phosphorylate Cdc10 on Ser-720 and Ser-732, we 
used an anti-phosphoserine antibody. As shown in Figure 5D, Cdc10 
is phosphorylated when cells are treated with MMS. However, when 
Ser-720 and Ser-732 were replaced by alanines, we were unable to 
detect this phosphorylation. In fact, and confirming the notion that 
the DNA damage checkpoint could be regulating the MBF com-
plex, we were able to detect direct interaction between Chk1 and 
Cdc10 by coimmunoprecipitation (Figure 5E)
To test whether Cdc10 phosphorylation by Chk1 is essential for 
in vivo regulation of Cdc10/MBF binding to its target promoters 
upon activation of the DNA damage checkpoint, we introduced 
serine-to-alanine mutations in fission yeast, replacing the endoge-
nous copy of cdc10. When treated with MMS, the strains that carry 
single mutations (including those next to the ankyrin domain) re-
sponded in a similar manner to a wild-type strain, that is, Cdc10 was 
released from its target promoters (Figure 6A and Supplemental 
Figure S3). However, in a strain that carries the double mutation 
S720AS732A (here Cdc10.2A) and cannot be phosphorylated in 
vitro and in vivo by Chk1, the release of Cdc10 was impaired from 
cdc18 promoter after treatment with MMS (Figure 6A). Of interest, 
we could observe only a small effect on the regulation of its binding 
activity to cdc22 promoter, pointing to the fact that Chk1 might dif-
ferentially regulate the binding of Cdc10 to only a subset of MBF-
dependent genes. A similar effect was observed when cells were 
irradiated (Figure 6B).
To test the consequences of the Chk1-mediated regulation of 
Cdc10 binding to chromatin, we measured the effect on transcrip-
tion. As expected, when a strain in which the two Chk1 phosphoryla-
tion sites were mutated to alanine (Cdc10.2A) was treated with in-
creasing doses of MMS, cdc18 transcription was steadily maintained, 
whereas cdc22 decreased to a similar extent as in the wild-type 
strain counterpart (Figure 6C; compare with Figure 3C). This differ-
ent response between two MBF-dependent genes led us to expand 
our set of analyzed genes and in a more quantitative manner by re-
verse transcriptase-quantitative PCR (RT-qPCR). As shown in Figure 
6D, whereas phosphorylation of Cdc10 by Chk1 is responsible for 
the down-regulation of cdc18 and cdt2, regulation of cdc22 and 
mik1 might be mediated by some other, overlapping mechanisms. 
Finally, we hypothesized that a strain in which the transcriptional 
lacking either Chk1 or the upstream activating kinase, Rad3, Cdc10 
was not released after treatment with MMS. Under these concentra-
tions of MMS, Yox1 release from chromatin paralleled the release of 
Cdc10, pointing to the possibility that it was the MBF complex as a 
whole that was released from chromatin when only the DNA dam-
age checkpoint was induced (Figure 4B).
Chk1 phosphorylates Cdc10 and inactivates 
MBF-dependent transcription
We then decided to focus on the possibility that Cdc10 itself could 
be a direct target of Chk1. In fact, Cdc10 was already described as 
a target for Cds1, although no clear phenotype was associated with 
Cdc10 mutants in the residues that are phosphorylated in vitro by 
Cds1 (Dutta et al., 2008), that is, Ser-720 and Thr-723. Because Cds1 
and Chk1 can phosphorylate similar target sequences (O’Neill et al., 
2002; Seo et al., 2003; Xu and Kelly, 2009), we set out to determine 
whether Cdc10 was in vitro a bona fide target for Chk1 
phosphorylation.
Cdc10 has four putative sites that can be phosphorylated by 
Chk1 (Ser-563, Thr-603, Ser-720, and Ser-732). Whereas the first two 
FIGURE 4: Cdc10 is released from chromatin upon DNA damage. 
(A) Loading of Cdc10 on cdc22 and cdc18 promoters was measured 
by ChIP analysis of chromatin extracts isolated from untreated or 
treated (0.1% MMS, 1 h at 30ºC) cultures of WT, Δcds1, Δchk1, 
Δcds1Δchk1, or Δrad3 cells. Endogenous Cdc10 is HA tagged, and 
the levels of binding are quantified on anti-HA immunoprecipitated 
DNA. (B) The same chromatin extracts were analyzed for Yox1 binding 
with anti-Yox1 polyclonal antibodies.
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et al., 2012) and might be conserved to 
some extent in higher eukaryotes. Yox1, the 
repressor of the MBF complex, is the main 
MBF target of fission yeast Cds1 (Aligianni 
et al., 2009; Gomez-Escoda et al., 2011). 
Yox1 phosphorylation by Cds1 results in its 
inactivation (Caetano et al., 2011; Gomez-
Escoda et al., 2011; Ivanova et al., 2011; 
Purtill et al., 2011). We now report here that 
the DNA damage checkpoint exerts a new 
layer of control on the MBF complex. How-
ever, instead of exerting a positive effect 
on MBF, Chk1, the effector kinase of the 
DNA damage checkpoint, is responsible for 
inactivating MBF-dependent transcription 
(Figure 7). This is achieved by direct phos-
phorylation of one of the core components 
of the MBF complex, Cdc10, at two differ-
ent sites on its carboxy-terminal domain. 
This phosphorylation induces the exit of 
Cdc10 from the chromatin and thus the re-
pression of the transcription of the MBF-
dependent genes. Of interest, low doses of 
MMS are able to induce MBF-dependent 
transcription (probably through Cds1-de-
pendent phosphorylation of Yox1), whereas 
high doses repress the same set of genes by 
directly phosphorylating Cdc10. In fact, un-
der such severe damage there is no active 
MBF complex associated with the corre-
sponding promoters, since Res1 and Res2 
are also released from chromatin (Figure 2, 
B and C). Our hypothesis is that cells that 
have to cope with severe DNA damage 
must stop any attempt to initiate DNA syn-
thesis, which will worsen its situation; this is 
achieved by switching off the S-phase tran-
scriptional program. However, fission yeast 
cells sense discrete or minor DNA damage 
(low MMS concentration, HU) at least partly 
as a block to DNA synthesis, activating the 
DNA replication checkpoint. Consequently, these cells need to 
maintain activated the transcriptional S-phase program until they 
manage to fully complete the duplication of its genome. In conclu-
sion, MBF would be doubly targeted by the DNA replication and 
the DNA damage checkpoints with outcomes that go in opposite 
directions: whereas the DNA damage checkpoint targets Cdc10 
and causes repression, the DNA replication checkpoint phosphory-
lates Yox1 and induces activation of transcription. Of interest, 
whereas all of the MBF-dependent genes are induced upon a chal-
lenge to DNA replication (Dutta et al., 2008; Gomez-Escoda et al., 
2011), only a subset seems to be under the control of the DNA 
damage checkpoint (Figure 6). We do not know how this is achieved, 
but it has long been known that not all MBF-dependent genes are 
regulated in the same manner; for example, in synchronized cul-
tures, transcription of cdc18 is induced in anaphase, whereas induc-
tion of cig2 takes place later during the G1-to-S transition (Baum 
et al., 1997). Thus the differential regulation of the MBF-dependent 
genes by the DNA damage checkpoint may be due to intrinsically 
differences in the chromatin structure of the two groups of MBF 
dependent genes; alternatively, we have not excluded that other 
components or regulators of the MBF complex can be overlapping 
response of the DNA damage checkpoint was abolished should 
have survival problems when confronted with a damaging agent, 
like MMS. As shown in Figure 6E, a strain carrying the double muta-
tion (Cdc10.2A) was sensitive to MMS. Of interest, this strain has a 
wild-type level of survival when confronted with drugs that block 
DNA replication (HU), indicating that these two residues are not 
regulated by the DNA replication checkpoint.
DISCUSSION
The MBF complex is an essential transcription factor that fission 
yeast cells need for the normal and controlled expression of the S-
phase transcription program. When DNA replication is challenged 
(e.g., after treatment of cells with HU), fission yeast cells activate 
their effector kinase (Cds1) and, among many other effects, are able 
to maintain a high level of MBF-dependent transcription (Gomez-
Escoda et al., 2011). Because ribonucleotide reductase (Cdc22) is 
the target of HU and its expression is directly regulated by MBF 
(Lowndes et al., 1992), hyperactivation of the complex might help to 
overcome the block to DNA replication inflicted by the drug. Similar 
processes have been described in the distantly related budding 
yeast (de Bruin et al., 2008; Bastos de Oliveira et al., 2012; Travesa 
FIGURE 5: Cdc10 Ser-720 and Ser-732 are phosphorylated by Chk1, inactivating MBF-
dependent transcription. (A) Chk1 signals MBF through the C-terminal region of Cdc10. Loading 
of Cdc10 on cdc22 and cdc18 promoters was measured in untreated or MMS-treated (0.1% 
MMS, 1 h at 25ºC) cultures of WT and cdc10-C4 strain by ChIP. Average of three individual 
experiments (±SD). (B) Amino acid sequence of the Cdc10 region phosphorylated by Chk1. The 
phosphorylation consensus is indicated at the bottom. (C) Chk1 in vitro kinase activity (in 
arbitrary units) was assayed using GST, WT, Cdc10, or the Cdc10 mutants indicated on top as 
substrates. Coomassie staining of the gel is shown at the bottom. (D) Cdc10 phosphorylation 
was determined on extracts prepared from untreated (unt.) or MMS-treated (0.1%) cells from 
WT (Cdc10) or Cdc10.2A strains. Immunoprecipitates were analyzed by Western blot with 
anti-phosphoserine (α-P-Ser) or anti-Cdc10 antibodies (α-Cdc10). (E) Extracts from the tagged 
strains indicated on top, untreated (unt) or treated with 0.1% MMS for 60 min, were 
immunoprecipitated with anti-Myc antibody and analyzed for the presence of Chk1 and Cdc10 
with specific antibodies (HA and Myc, respectively). Left, Western blot of the whole-cell extracts 
used in the immunoprecipitations.
Volume 24 November 1, 2013 DDR represses G1-to-S transcription | 3355 
resulting in cells being directed to apopto-
sis (Stevens et al., 2003). However, another 
report demonstrated that irradiation might 
also cause phosphorylation of Rb (by 
Chk1/2) on a site that is also phosphory-
lated by CDK/cyclins in unperturbed cell 
cycle. Intriguingly, phosphorylation of Rb 
on this site induces repression of E2F-de-
pendent transcription (Inoue et al., 2007). 
We propose that the checkpoint regulation 
of transcription through Cdc10 might be 
distantly conserved across eukaryotes, with 
the same final outcome (repression of tran-
scription after DNA damage), but using 
highly divergent mechanisms: whereas in 
higher eukaryotes phosphorylation tethers 
the repressor (Rb) to the transcription fac-
tor (E2F-1), in fission yeast it decreases the 
binding of the transcription factor to its 
cognate promoters. It will be interesting to 
know whether similar mechanisms are con-
served in the distantly related budding 
yeast.
MATERIALS AND METHODS
Strains and media
All S. pombe strains are isogenic to wild-
type 972h-. The strains used in this work are 
listed in Supplemental Table S1. Media were 
prepared as previously described (Moreno 
et al., 1991). HU (10 mM), MMS, and 
γ-irradiation treatment were carried out on 
mid-log-grown cultures ([3–4] × 106 cells/ml) 
in YE5S media. Liquid cultures were treated 
with HU for 4 h and to MMS for 60 min, 
unless otherwise indicated. To analyze sen-
sitivity to HU and MMS on plates, S. pombe 
strains were grown in liquid YE5S media to 
an OD600 of 0.5. Cells were then diluted in 
YE5S and spotted onto YE5S media agar 
plates. Plates were incubated at 30°C for 
3–4 d.
Viability assays
For viability tests, cells were grown in liquid 
YE5S media to an OD600 of ∼0.3, and the 
cultures were treated with MMS. For pro-
pidium iodine staining, cells were centri-
fuged, washed twice with phosphate-buff-
ered saline (PBS), and incubated with 
3 μg/ml dye for 40 min on ice in darkness. 
For phloxine B staining, cells were incubated with 5 μg/ml dye for 
2 h with shaking at 30°C in darkness, centrifuged, and washed twice 
with PBS. Ten thousand cells from each sample were scanned using 
channel FL3 for propidium iodide and channel FL2 for phloxine B 
with FACSCalibur (BD Biosciences, San Jose, CA).
Protein extraction
Extracts were prepared in NET-N buffer (20 mM Tris HCl, pH 8.0, 
100 mM NaCl, 1 mM EDTA, 0.5% NP40, 1 mM dithiothreitol [DTT], 
1 mM phenylmethylsulfonyl fluoride, 5 μg/ml aprotinin, protease 
inhibitor cocktail [Sigma-Aldrich, St. Louis, MO], 2 mM NaF, 0.2 mM 
targets for Chk1 and play a role in only a subset of MBF-dependent 
genes. Further work is required to characterize this differential 
regulation.
Although a clear link had not been demonstrated in higher eu-
karyotes between the DNA replication checkpoint and the regula-
tion of the expression of S-phase genes, previous reports implied 
a connection between the DNA damage checkpoint and E2F, 
which, to some extent, is the functional homologue of fission yeast 
MBF and budding yeast MBF/SBF (Stevens et al., 2003; Inoue 
et al., 2007; Zalmas et al., 2008). Initially it was reported that E2F-1 
was phosphorylated and activated in response to DNA damage, 
FIGURE 6: Cdc10 phosphorylation after DNA damage is essential for viability. (A) Loading of 
Cdc10 on cdc22 and cdc18 promoters was measured by ChIP analysis of chromatin extracts 
isolated from untreated or treated (0.1% MMS, 1 h at 30ºC) cultures of WT Cdc10 or the 
mutants indicated at the bottom. (B) Phosphorylation of S720 and S732 after ionizing radiation 
(IR) induces the release of Cdc10 from chromatin. Loading of Cdc10 on cdc22 and cdc18 
promoters was measured by ChIP analysis of chromatin extracts isolated from untreated or IR 
(100 Gy) cultures of WT and Cdc10.2A cells. Average of three individual experiments (±SD). 
(C) Total RNA was prepared from untreated or MMS-treated (increasing doses) cultures of a 
cdc10.2AΔyox1Δnrm1 strain and analyzed by hybridization with the probes indicated on the left. 
rRNA is shown as loading control. (D) RNA was prepared from wild-type (Cdc10) or Cdc10.2A 
cells exponentially growing or treated with 0.1% MMS for 1 h. cdc18, cdt2, cdc22, and mik1 
were quantitated by RT-qPCR. Results are shown as fold induction over untreated wild-type cells 
as the average of three individual experiments (±SD). (E) Survival was performed by spotting 
10–105 cells of the indicated strains (in a Δyox1Δnrm1 background) onto YE5S plates in the 
absence or presence of MMS or HU. Plates were incubated at 30°C for 3–4 d.
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extracted, and precipitated. Eight micrograms of total RNA was de-
natured at 65°C for 10 min and then chilled on ice. Reverse tran-
scriptase reactions were carried out (60 min at 42°C, 30 min at 52°C, 
and 3 min at 94°C) following the manufacturer’s guidelines (Pro-
mega, Madison, WI) in the presence or absence of the enzyme. One 
microliter of the cDNA was used in the RT-qPCR with specific 
oligonucleotides.
Chromatin immunoprecipitation
Chromatin immunoprecipitation experiments were performed as 
described (Moldon et al., 2008). All experiments are plotted as the 
average of at least three different biological replicates ± SD and 
represented as relative binding with respect to untreated wild-type 
cells to facilitate comparison between different strains.
Na3VO4, 2 mM β-glycerophosphate). Cells were broken with glass 
beads in a Minibeadbeater (BioSpec, Bartlesville, OK). Immunopre-
cipitations (1–3 mg of whole-cell lysate) were performed with 10 μl 
of protein G–Sepharose previously cross-linked with anti-hemagglu-
tinin (HA) monoclonal antibody. Immunoprecipitates were washed 
after 1 h of incubation three times with NET-N buffer and resolved in 
SDS–PAGE, transferred to nitrocellulose membranes, and blotted 
with the indicated antibody. In Figure 5D, the detection of phospho-
rylated Cdc10 was performed using purified mouse anti-phospho-
serine/threonine monoclonal antibody (612548; BD Biosciences).
In vitro Chk1 kinase assay
Substrates were prepared as glutathione S-transferase fusion pro-
teins in Escherichia coli as described (Dutta et al., 2008). Protein 
extracts (300 μg) from MMS-treated cultures of a strain with HA-
tagged Chk1 were immunoprecipitated as described (Ayte et al., 
2001), followed by three washes with NET-N buffer and one wash 
with kinase buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid, pH 7.5, 20 mM MgCl2, 4 mM EGTA, 2 mM DTT). 
Immunoprecipitates were incubated in kinase buffer containing 2 μg 
of substrate and 10 μCi of [γ-32P]ATP for 30 min at 30°C. Labeled 
proteins were resolved in 12% SDS–PAGE and detected by 
autoradiography.
Gene expression analysis
RNA extraction was performed as described (Moldon et al., 2008), 
and 10 μg of extracted RNA was loaded on agarose gels and ana-
lyzed by Northern blot. cdc18, cdc22, and tfb2 probes contained 
the complete open reading frames of the genes. For the RT-qPCR, 
RNA was digested with DNase I for 30 min at 37°C, phenol 
FIGURE 7: A model for the integration of the DNA damage and the 
DNA replication checkpoints on the MBF complex. On replicative 
stress, fission yeast cells activate the effector kinase Cds1. Among its 
targets, the repressor Yox1 is phosphorylated and no longer can bind 
the MBF complex, alleviating the transcriptional repression of genes 
required for DNA synthesis. On DNA damage, the effector kinase 
Chk1 phosphorylates Cdc10, which is a core component of the MBF 
complex. The outcome of this phosphorylation is, contrary to what 
happens under replicative stress, release of Cdc10 from its target 
promoters and repression of MBF-dependent transcription.
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